National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

flurbiprofen
A derivative of propionic acid, and a phenylalkanoic acid derivative of non-steroidal antiinflammatory drugs (NSAIDs) with analgesic, antiinflammatory and antipyretic effects. Flurbiprofen non-selectively binds to and inhibits cyclooxygenase (COX). This results in a reduction of arachidonic acid conversion into prostaglandins that are involved in the regulation of pain, inflammation and fever. This NSAID also inhibits carbonic anhydrase, thereby reducing the production of hydrogen and bicarbonate ions. Upon ocular administration, flurbiprofen may reduce bicarbonate ion concentrations leading to a decrease in the production of aqueous humor, thereby lowering intraocular pressure. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Ansaid
Code names:BTS 18,322
E-7869
MPC-7869
U-27,182
Chemical structure name:2-fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid



Previous:Fluoroplex, fluorouracil, fluorouracil-e therapeutic implant, fluoxymesterone, fluphenazine hydrochloride
Next:Flurizan, Flushield, flutamide, fluvastatin sodium, Fluvirin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov